FDA relaxes controversial restrictions on access to abortion pill by mail
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.
Stay updated with breaking news from Devos Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.
The agency's decision to ease access to the drug mifepristone comes at a time when abortion rights are being increasingly restricted nationwide.
Before the pandemic, doctors like Nisha Verma could only prescribe abortion pills to patients who came to her clinic in person.
The abortion pill mifepristone was approved in 2000 but still faces layers of restrictions. Advocates want the FDA to permanently allow patients to receive the pill by mail instead of in person.
Before the pandemic, doctors like Nisha Verma could only prescribe abortion pills to patients who came to her clinic in person. But at least for now, the